Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
NCT06303622

Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial

Led by Chinese University of Hong Kong · Updated on 2026-02-17

1250

Participants Needed

1

Research Sites

116 weeks

Total Duration

On this page

Sponsors

C

Chinese University of Hong Kong

Lead Sponsor

N

Nanjing Drum Tower Hospital, China

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study is an international multicentre RCT to compare the linically significant prostate cancer (csPCa) detection of cognitive-guided and MRI-USG guided biopsies in men with suspicious MRI lesion.

CONDITIONS

Official Title

Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Men 18 years of age or older
  • Clinical suspicion of prostate cancer and recommended for prostate biopsy
  • Serum Prostate-specific antigen (PSA) less than 20 ng/mL
  • Digital rectal examination showing organ-confined cancer (stage cT2 or less)
  • Able to provide written informed consent
  • MRI prostate (contrast or plain) showing 1 to 3 suspicious lesions with PI-RADS score 3 to 5
Not Eligible

You will not qualify if you...

  • Prior prostate biopsy within 2 years before screening visit
  • Prior diagnosis of prostate cancer
  • Contraindications to prostate biopsy including active urinary tract infection, failed insertion of transrectal ultrasound probe (due to abdominal perineal resection or anal stenosis), uncorrectable coagulopathy
  • Use of antiplatelet or anticoagulant medications that cannot be stopped (low-dose aspirin allowed before and after biopsy)
  • Patient refusal to undergo biopsy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Prince of Wales Hospital

Hong Kong, Hong Kong

Actively Recruiting

Loading map...

Research Team

P

Peter Ka-Fungq CHIU, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here